INS and Hyperinsulinemia: The higher degree of insulin resistance might induce insufficient insulin secretion after treatment with glycemic control agents, especially those targeting in improving insulin secretion, and result in a poor response in glucose control management, which might lead to persistent hyperinsulinemia and hyperglycemia [26].